Based on dichotomized IRS scores, our cohort study revealed that KIF14 protein might be more frequently upregulated (55.88%) than downregulated (44.12%) in pancreatic ductal adenocarcinoma tissues, and that the former expression status independently conferred a better prognosis. The gene discussed is KIF14; the disease is pancreatic ductal adenocarcinoma.